Core Insights - INmune Bio, Inc. is participating in the Dermatologic Rare Disease Panel at the Maxim Growth Summit on October 22-23, 2025, where CEO David Moss will discuss the company's CORDStrom™ platform for treating Recessive Dystrophic Epidermolysis Bullosa (RDEB) [1][2] Company Overview - INmune Bio, Inc. is a clinical-stage biotechnology company focused on developing treatments targeting the innate immune system to combat diseases [3] - The company has three product platforms: - Dominant-Negative Tumor Necrosis Factor (DN-TNF) platform, which neutralizes soluble TNF to address immune dysfunction [3] - CORDStrom™, a proprietary platform using human umbilical cord-derived mesenchymal Stromal/Stem cells, which has completed a blinded randomized trial for RDEB [3] - INKmune®, designed to enhance natural killer cells to eliminate minimal residual disease in cancer patients, currently in trials for metastatic castration-resistant prostate cancer [3] Event Details - The Maxim Growth Summit will be held at the Hard Rock Hotel in New York City, with David Moss available for one-on-one meetings throughout the conference [1][2]

Core Insights - Roadzen Inc. is participating in two investor conferences in New York City in October 2025, showcasing its advancements in AI technology within the insurance and mobility sectors [1][2] Group 1: Upcoming Events - Roadzen's executive team will attend the 2025 Maxim Growth Summit on October 22-23, where Rohan Malhotra will discuss impactful AI use cases on a panel [1] - At the ThinkEquity Conference on October 30, Rohan Malhotra will present at 1:00 p.m. ET [2] Group 2: Company Achievements - Roadzen will highlight its recent achievements, including expanding partnerships and technology milestones, particularly the regulatory validation and rapid adoption of its DrivebuddyAI platform [2] - The company is scaling globally, expanding margins, and building a significant real-world driving intelligence network that provides value in risk intelligence, safer driving, and smarter insurance solutions [2] Group 3: Company Overview - Roadzen Inc. is a global technology company focused on transforming auto insurance through advanced AI, serving thousands of clients including leading insurers and car manufacturers [4] - The company has been recognized as a top AI innovator by major publications and aims to advance AI research at the intersection of mobility and insurance [4] - Headquartered in Burlingame, California, Roadzen employs 323 people across its offices in the U.S., U.K., and India [4]

Core Insights - Co-Diagnostics, Inc. will participate in the 2025 Maxim Growth Summit on October 22-23 at The Hard Rock Hotel NYC [1] - The summit will feature industry leaders and discussions on various sectors including biotechnology, artificial intelligence, and energy [2] - Co-Diagnostics will engage in one-on-one meetings with institutional investors and senior analysts during the event [3] Company Overview - Co-Diagnostics, Inc. is a molecular diagnostics company based in Utah, specializing in the development of advanced diagnostic technologies [5] - The company's proprietary technology is designed for tests that detect and analyze nucleic acid molecules (DNA or RNA) [5] - Co-Diagnostics is also working on specific tests for its Co-Dx PCR at-home and point-of-care platform, which is currently under regulatory review [5]

As filed with the Securities and Exchange Commission on September 25, 2025 Registration No. 333-289965 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 PRE-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 ON FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Signing Day Sports, Inc. (Exact name of registrant as specified in its charter) Delaware 7389 87-2792157 (I.R.S. Employer Identification Number) 8355 East Hartford Rd., Suite 100 Scottsdale, AZ 85255 (480) 220-6814 (Address, in ...

Core Viewpoint - Rock Tech Lithium Inc. has announced the receipt of irrevocable subscription agreements for a total of $4.8 million through a private placement offering of units priced at $0.90 per unit, which includes both brokered and non-brokered offerings [1][3][6]. Group 1: Offering Details - The offering consists of units that include one common share and one common share purchase warrant, with the warrant exercisable at $1.17 for three years [3][6]. - The Brokered Offering is managed by Maxim Group LLC as the sole placement agent [2]. - The expected closing date for the offerings is around September 3, 2025, and may occur in multiple tranches [4][8]. Group 2: Additional Offerings - The company plans to offer up to 2,975,111 additional units for gross proceeds of up to $2.678 million on a non-brokered basis, targeting select Canadian and offshore institutional investors [5][6]. - The total offering may be increased by an additional $2.5 million based on investor demand, potentially raising total gross proceeds to $10 million [6]. Group 3: Use of Proceeds - The net proceeds from the offerings are intended to fund the advancement of the Guben Converter project and for general corporate and working capital purposes [6]. Group 4: Company Overview - Rock Tech Lithium aims to enhance the battery supply chain in Europe and North America by producing high-quality lithium, supporting a sustainable and transparent value chain [10][11]. - The company operates lithium hydroxide converter projects in Guben, Germany, and Ontario, Canada, with a focus on responsible sourcing and circular economy principles [11][12].

Core Points - NMP Acquisition Corp. will allow holders of its units to separately trade Class A ordinary shares and rights starting September 3, 2025 [1][2] - The Class A ordinary shares and rights will trade on Nasdaq under the symbols "NMP" and "NMPAR," respectively, while units not separated will continue to trade under "NMPAU" [2][3] - Each unit consists of one Class A ordinary share and one right, with each right entitling the holder to receive one-fifth (1/5) of a Class A ordinary share upon the completion of the company's initial business combination [3] Company Overview - NMP Acquisition Corp. is a Cayman Islands exempt company formed as a blank check company, also known as a special purpose acquisition company (SPAC), aimed at effecting business combinations [5] - The management team includes Melanie Figueroa as CEO and Nadir Ali as CFO, both with significant experience in operating and capital markets transactions [5]

Company Overview - Eastern International Ltd. is a provider of domestic and cross-border professional logistic services, including project logistic and general logistic for clients [6] - The company operates through its wholly owned subsidiary, Suzhou TC-Link Logistics Co., Ltd., which was established in 2006 and has a network covering key cities in mainland China, Hong Kong, Southeast Asia, and Central Asia [6] Offering Details - Eastern International announced a public offering of 1,600,000 ordinary shares priced at $4.00 per share, with expected gross proceeds of approximately $6.4 million if the over-allotment option is not exercised [1][2] - The company has granted Maxim Group LLC a 45-day option to purchase an additional 240,000 shares at the initial public offering price [2] - The shares are expected to begin trading on the Nasdaq Capital Market under the ticker symbol "ELOG" on August 28, 2025, with the offering expected to close on August 29, 2025 [3] Regulatory Information - The offering is conducted pursuant to the Company's Registration Statement on Form F-1, which was declared effective by the U.S. Securities and Exchange Commission on August 27, 2025 [4]

Core Viewpoint - Jet.AI Inc. has made a capital contribution to AIIA Sponsor Ltd., which is sponsoring AI Infrastructure Acquisition Corp., a special purpose acquisition company aiming for an initial public offering (IPO) focused on AI and machine learning technology companies [1][2]. Group 1: Company Overview - Jet.AI Inc. is a provider of high-performance GPU infrastructure and AI cloud services, transitioning to a pure-play AI data center company [5]. - The company was founded in 2018 and is based in Las Vegas, NV, operating in two segments: Software and Aviation [5]. - Jet.AI aims to build scalable, high-performance infrastructure to meet the growing computational demands of artificial intelligence [5]. Group 2: IPO Details - AI Infrastructure Acquisition Corp. plans to conduct an IPO with a base offering size of $100 million, potentially increasing to $115 million if the underwriters fully exercise their over-allotment option [2]. - The IPO will focus on high-impact private technology companies that advance AI and machine learning capabilities, as well as those involved in next-generation data center infrastructure [2]. - Maxim Group LLC is acting as the sole book-running manager for the IPO [3].

Company Overview - Ocugen, Inc. is a biotechnology leader specializing in gene therapies for blindness diseases, focusing on a modifier gene therapy platform that addresses complex diseases caused by imbalances in multiple gene networks [5] Offering Details - The company closed a registered direct offering with Janus Henderson Investors for 20,000,000 shares of common stock at a price of $1.00 per share, along with warrants to purchase an additional 20,000,000 shares at an exercise price of $1.50 per share [1][3] - The gross proceeds from the offering were approximately $20 million, which is expected to extend the company's cash runway into the second quarter of 2026 [3] - If the warrants are fully exercised, the company could receive up to an additional $30 million, potentially extending the cash runway into the first quarter of 2027 [3] Financial Advisors - Noble Capital Markets, Inc. acted as the sole placement agent for the offering, while Maxim Group LLC and Titan Partners Group served as independent financial advisors [2]

Core Viewpoint - AmpliTech Group, Inc. is set to release its Q2 2025 earnings report on August 14, 2025, and will host an investor conference call on the same day to discuss the results [1]. Company Overview - AmpliTech Group, Inc. is a designer, developer, and manufacturer of advanced signal processing components for various communication networks, including satellite, Public and Private 5G, and 6G systems [1][3]. - The company operates through five divisions: AmpliTech Inc., Specialty Microwave, Spectrum Semiconductors Materials, AmpliTech Group Microwave Design Center, and AmpliTech Group True G Speed Services [3]. - AmpliTech serves global markets such as satellite communications, telecommunications (5G & IoT), space exploration, defense, and quantum computing, focusing on technology and innovation [3]. Investor Call Details - The investor conference call is scheduled for August 14, 2025, at 5:00 PM ET, with dial-in numbers provided for both domestic and international participants [2]. - An audio file and transcript of the call will be made available on AmpliTech's news page after the event [2].